Stay Updated

Get a weekly digest of the latest psychedelic research, new studies, and platform updates delivered to your inbox.

No spam, ever. Unsubscribe anytime.

The neurobiology of psychedelic drugs: implications for the treatment of mood disorders

ObservationalManualAugust 18, 2010DOI

Authors (2)

Franz X. VollenweiderLeadUniversity of Zurich

Michael KometerFranz X. Vollenweider and Michael Kometer are at the Neuropsychopharmacology and Brain Imaging Research Unit, University Hospital of Psychiatry, Zurich, Switzerland.,

MeSH Terms

PsilocybinHallucinogenLysergic acid diethylamideNeurosciencePsychologyMoodMood disordersDissociativeNeuroimagingPsychiatryPsychotherapistPsychedelics and Drug StudiesNeurotransmitter Receptor Influence on BehaviorTryptophan and brain disorders

Comments(0)

Metadata

Study TypeObservational

SourceManual

Publication DateAugust 18, 2010

Citations701

External Links

DView DOI

X LinkedIn Email